How Palantir got into the NHS

The podcast discusses Palantir's controversial contract with the NHS, valued at £330 million, to develop a digital platform aimed at improving patient data integration. Investigative journalist Lucas Armin and his colleague Peter Gagan examined how Palantir, known primarily for its military and surveillance software, won this contract amidst concerns over data privacy and the functionality of its products.

The episode outlines Palantir's rise in the UK, beginning with its initial contracts and strategic lobbying efforts spearheaded by its PR consultants. It details how the company positioned itself as a crucial player during the COVID-19 crisis, securing NHS contracts by offering services at a nominal fee as part of a 'land and expand' strategy. Despite initial optimism, the rollout of Palantir’s Federated Data Platform (FDP) revealed significant issues; low usage rates among NHS trusts indicated that the software failed to meet the needs and expectations of healthcare professionals.

The conversation highlights the concerns regarding the effectiveness of Palantir's products, with doctors and health officials reporting a downgrade in functionality compared to existing systems. Furthermore, the episode sheds light on the implications of data access and control, raising questions about patient privacy and the overall management of healthcare data. As the contract's renewal approaches, there are increasing calls for the NHS to reconsider its relationship with Palantir, indicating that its days in the NHS may be numbered.